Savaria Q4 2025 Adjusted EBITDA Reaches $51.3M, an increase of 19.7%
Go back to Savaria Q4 2025 Adjusted EBITDA Reaches $51.3M, an increase of 19.7%| Isis Pharmaceuticals, Inc. (NASDAQ: SIS) | Delayed: 5.00 +0.08 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.92 | 52 Week High | $5.09 | |||
| Open | $4.95 | 52 Week Low | $4.75 | |||
| Day High | $5.09 | P/E | N/A | |||
| Day Low | $4.75 | EPS | $-1.63 | |||
| Volume | 70,734 | |||||

